CRISPR-based diagnostics for circulating cell-free DNA: a paradigm shift in precision oncology
CRISPR-Cas technology is being integrated into advanced biosensing platforms, creating powerful tools for the rapid, precise, and sensitive cfDNA-based cancer detection.
Authors
- Sahil Seth (ORCID: https://orcid.org/0000-0003-4579-3959)
- K. Sudhakara Prasad (ORCID: https://orcid.org/0000-0002-3739-8011)
Institutions
- Yenepoya University (IN)
Publication Details
- Journal
- Sensors & Diagnostics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5sd00083a
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Postgraduate Institute of Medical Education and Research, Chandigarh